Investors in Fund

Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.

FI Nvest is an investment vehicle that invests in startups. FI Group is a global consulting company specializing in managing R&D tax reliefs and grants to finance innovation for companies worldwide. The FI Group is a Global Consulting Company specialising in the management of funding incentives such as R&D Tax Reliefs and R&D Grants. FI Group helps companies finance innovation and secure funding for their Research and Development (R&D) activities through the comprehensive management of R&D Grants and Tax incentives.

DKV Mobility is the leading European B2B platform for on-the-road payments and solutions.DKV Mobility is the top European B2B platform for on-the-road payments, providing fuel cards, toll solutions, smart fleet management, and e-mobility services to streamline fleet operations.

Arabella Venture Capital AG bridges the gap between the present and the future. We keep good ties with the major start-up hubs in Europe, the United States of America, and Asia. Founded in 2019, Arabella Venture Capital AG connects the present with the future. We maintain close relationships with the major start-up hubs in Europe, the United States of America and Asia.

Zaz Ventures has helped deeptech innovators to raise 1.1Bn Euros of EC funding since 2014. We provide fundraising advisory services (identifying funding instruments, preparing hybrid funding application combining grant and equity) across a variety of domains (ICT, Robotics, Security, Space, Transportation, Manufacturing, Nanomaterials, Health, Agri-Food, Energy, Raw Materials, Environment). We have offices in Brussels, London, Paris, Stans, Krakow and Madrid. All our projects are carried out on a no-win-no-pay basis. This means that we only invoice our services when (and if) the client receives public funding. This formula is particularly attractive for very competitive schemes where the average success rate is currently below 5%, such as the EIC Accelerator.

Sequoia Economic Infrastructure Income Fund invests in economic infrastructure private loans and bonds across a range of industries in stable, low-risk jurisdictions creating equity-like returns with the protections of debt.

Chroma Ventures channels flexible capital into a range of early-stage and established businesses with high-growth potential. Burns and van der Kuyl have been active supporters – both financially and practically – of a broad range of companies for several years, often in collaboration with other investors. Their portfolio includes direct investments that have grown into significant stakes in well-established businesses, such as global leader in cross-platform TV ad measurement TVS quared, cupboard stored ready meal provider Parsley Box, commercial insurance distribution and data platform Broker Insights, and indie game studio Puny Astronaut.

Straightforward Capital is a venture capital company that helps companies to unleash their growth potential. Straightforward Capital invests into companies that are in their early growth stage. We consider Finnish high-tech sector as our home market. Our fund acquires minority stakes in technology companies and plays an active role in their strategic planning and development. During the investment process we have always the ambition to be the leading investor and add value to this process by our experience. Our initial investments range from 500 thousand to 2 million euros.

Siena Secondary Fund provides liquidity for early investors, founders and employees of high growth startups from the Nordics & CEE region. We target companies which are usually post series A, have solid business model and are still in high growth phase.

Claris Ventures SGR makes equity investments in early-stage biopharma companies with a clear vision and solid scientific evidence. We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas. We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence. Claris Biotech I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing" (or the relevant translation).

We partner with stellar entrepreneurs to realize their unique intuitions and reach their goals, inspired by values. Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and our advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources. We are sector agnostic and target innovative opportunities around the world. We share goals and passion with founders and look to connect them with our wide international network to bridge their expansion domestically as well as overseas. Investment Criteria Focus on Early Stage and Growth phases rounds for companies offering innovative products / services operating within a large addressable market. Target investments should ideally have potential for international expansion.

Delirus Capital is a founder-focused investment firm that provides early-stage funding to exceptional founders across Europe, the UK, and the US.Delirus Capital helps to invset in consumer-focused businesses where it could draw on its branding and community-building experience.